0001209191-17-041644.txt : 20170623 0001209191-17-041644.hdr.sgml : 20170623 20170623162243 ACCESSION NUMBER: 0001209191-17-041644 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170622 FILED AS OF DATE: 20170623 DATE AS OF CHANGE: 20170623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deeg Mark Albert CENTRAL INDEX KEY: 0001708820 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 17927825 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS INC. STREET 2: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-22 0 0001505512 Regulus Therapeutics Inc. RGLS 0001708820 Deeg Mark Albert C/O REGULUS THERAPEUTICS 10614 SCIENCE CENTER DR. SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 0.99 2017-06-22 4 A 0 100000 0.00 A 2017-06-21 Common Stock 100000 100000 D 25% of the shares vest on June 22, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on June 22, 2021. Christopher Aker, Attorney in Fact 2017-06-23